0 results available. Select is focused ,type to refine list, press Down to open the menu,
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the tre...
The following section summarizes insights on Assertio Therapeutics Inc's Capital Expenditures:
We've identified the following companies as similar to Assertio Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Capital Expenditures in the financials category include:
The overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sale...
Capital expenditures or CAPEX represents spending on assets that are enjoyed over a long period of time. Common examples of capital expenditures include office buildings, machines, and vehicles.
Capital expenditures can be found on a company’s cash flow statement under “Investing Activities” and increases fixed assets located on the Balance Sheet
Assertio did not report meaningful capital expenditures for the latest twelve months ending December 31, 2024 on its income statement.
The tables below summarizes Assertio’s capital expenditures and common size over the last five years:
| Fiscal Year | Capital Expenditures | Revenue | % Revenue |
|---|---|---|---|
| 2020-12-31 | 10 T | 108.1 M | 0.0% |
| 2021-12-31 | 53 T | 111 M | 0.0% |
| 2022-12-31 | 274 T | 156.2 M | 0.2% |
| 2023-12-31 | 628 T | 152.1 M | 0.4% |
| 2024-12-31 | NA | 125 M | 0.0% |
The tables below summarizes Assertio’s capital expenditures and common size over the last four quarters:
| Quarter Ending | Capital Expenditures | Revenue | % Revenue |
|---|---|---|---|
| 2024-03-31 | NA | 32.448 M | 0.0% |
| 2024-06-30 | NA | 31.126 M | 0.0% |
| 2024-09-30 | NA | 29.204 M | 0.0% |
| 2024-12-31 | NA | 32.183 M | 0.0% |
The chart above depicts the distribution of capital expenditures for companies operating in the Healthcare sector in the Developed economic region. Over 2,010 companies were considered in this analysis, and 1,946 had meaningful values. The average capital expenditures of companies in the sector is 26.132 M with a standard deviation of 87.753 M.
Assertio Therapeutics Inc's Capital Expenditures of - ranks in the - percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,012 |
| Included Constituents | 1,946 |
| Min | 0 K |
| Max | 755.9 M |
| Median | 522.806 K |
| Mean | 26.132 M |
| Standard Deviation | 87.753 M |
You can find companies with similar capital expenditures using this stock screener.